ATRINSIC, INC COM STK (ATRNQ)
followers
·
Follow
Sector:
CONSUMER DISCRETIONARY
Industry:
ENTERTAINMENT
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Garo H. Armen
Employees:
2
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
(212) 994-8200
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- Atrinsic Inc
- Atrinsic, Inc.
- Atrinsic, Inc.
| Date | Ratio |
|---|---|
| 2007-05-03 | 1:3 |
| 2010-12-03 | 1:4 |
Protagenic Therapeutics, Inc. engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|